Other TRPV4 antagonists, HC-067047, GSK2193874, and GSK2798745, have also demonstrated positive effects in improving retinal edema and ischemia in RVO mice, being able to inhibit the VEGF-induced vascular hyperpermeability [74]. This evidence concerns the gene TRPV4 and retinal edema.